Skip to main content
. 2020 Mar 16;10:4846. doi: 10.1038/s41598-020-61854-x

Figure 1.

Figure 1

CNV tracks for a paired normal/cancer samples deposited in GEO with sample IDs GSM276881 and GSM276880. GSM276880 is a glioblastoma sample. GSM276881 is its peripheral blood control. The CNV tracks are consisted of two panels. Upper panel indicates the total copy number, represented by logR ratio (log2copynumberreferencecopynumber at any probe) Namely, logR = 0 indicates a position with normal two copies, logR > 0 indicates a copy number gain and logR < 0 indicates a copy number loss. Lower panel indicates the allele specific copy number, represented by B-allele frequency (BAF, No.BallelecopyTotalcopynumber). Any given SNP position can have a value between 0 and 1. A line at 0.5 indicates a heterozygous region. Compared to the unaltered genome (A), the cancerous counterpart (lower) has copy number loss in chr8, 10p, 18, 19qter, 22q and copy-neutral loss of heterozygocity in chr9,12q, accounting for 18.2% of genome.